MCA
TCRT icon

Magnolia Capital Advisors’s Alaunos Therapeutics TCRT Stock Holding History

Magnolia Capital Advisors’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,470
Closed -$27.7K – 160
2024
Q1 		$27.7K Sell
2,470
-207
-8% -$4.14K 0.02% 91
2023
Q4 		$65.4K Sell
2,677
-209
-7% -$2.52K 0.05% 90
2023
Q3 		$32.8K Buy
+2,886
New +$124K 0.03% 64
2023
Q2 		– Sell
-2,990
Closed -$283K – 151
2023
Q1 		$283K Buy
2,990
+158
+6% +$15K 0.15% 121
2022
Q4 		$276K Buy
2,832
+42
+2% +$6.09K 0.18% 114
2022
Q3 		$720K Buy
2,790
+559
+25% +$162K 0.61% 54
2022
Q2 		$414K Buy
2,231
+995
+81% +$95.1K 0.38% 83
2022
Q1 		$121K Buy
1,236
+420
+51% +$53.9K 0.05% 189
2021
Q4 		$133K Buy
816
+128
+19% +$28.1K 0.04% 195
2021
Q3 		$188K Buy
688
+35
+5% +$10.7K 0.07% 176
2021
Q2 		$258K Buy
+653
New +$305K 0.11% 119
2021
Q1 		– Sell
-585
Closed -$221K – 125
2020
Q4 		$221K Buy
585
+49
+9% +$19.5K 0.14% 105
2020
Q3 		$202K Sell
536
-68
-11% -$30K 0.16% 97
2020
Q2 		$297K Sell
604
-7
-1% -$3.12K 0.38% 56
2020
Q1 		$225K Sell
611
-57
-9% -$29.5K 0.44% 64
2019
Q4 		$472K Buy
+668
New +$460K 0.45% 38

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

Magnolia Capital Advisors's TCRT Position: Q2 2024 in Review

Magnolia Capital Advisors sold out of Alaunos Therapeutics (TCRT) in Q2 2024, closing a stake of 2,470 shares — an estimated $27.7K sold.

Magnolia Capital Advisors first reported a position in TCRT in Q4 2019 and held it in 16 quarters. The position peaked at $720K in Q3 2022. 50 funds tracked by Wall St. Rank hold TCRT as of Q2 2024.

  • Magnolia Capital Advisors reported no remaining Alaunos Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Magnolia Capital Advisors sold 2,470 Alaunos Therapeutics shares in Q2 2024, an estimated $27.7K.
  • Magnolia Capital Advisors first reported a position in Alaunos Therapeutics in Q4 2019 and held it in 16 quarters.
  • Magnolia Capital Advisors's Alaunos Therapeutics position peaked at $720K in Q3 2022.
  • 50 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2024.

Based on Magnolia Capital Advisors's 13F filing for Q2 2024, filed 15 Aug 2024.